Align TechnologyALGN
Market Cap: 16.6B
About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Employees: 21,670
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
50% more funds holding in top 10
Funds holding in top 10: 4 [Q4 2023] → 6 (+2) [Q1 2024]
27% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 83
19% more capital invested
Capital invested by funds: $17.7B [Q4 2023] → $21.1B (+$3.39B) [Q1 2024]
3% more funds holding
Funds holding: 759 [Q4 2023] → 781 (+22) [Q1 2024]
1.38% more ownership
Funds ownership: 84.3% [Q4 2023] → 85.68% (+1.38%) [Q1 2024]
7% more repeat investments, than reductions
Existing positions increased: 292 | Existing positions reduced: 272
44% less call options, than puts
Call options by funds: $375M | Put options by funds: $668M
Research analyst outlook
19 Wall Street Analysts provided 1 year price forecasts over the past 6 months
19 analyst ratings
Morgan Stanley Erin Wright | 41%upside $310 | Overweight Maintained | 25 Jul 2024 |
Stifel Jonathan Block | 59%upside $350 | Buy Maintained | 25 Jul 2024 |
Piper Sandler Jason Bednar | 43%upside $315 | Overweight Maintained | 25 Jul 2024 |
Baird Jeff Johnson | 47%upside $325 | Outperform Maintained | 22 Jul 2024 |
Piper Sandler Jason Bednar | 50%upside $330 | Overweight Maintained | 10 Jul 2024 |
Financial journalist opinion
Based on 16 articles about ALGN published over the past 30 days